Pediatric Neurology Device Market Size, Share, Forecast, 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Pediatric Neurology Device Market Size Analysis

Global Pediatric Neurology Device Market Introduction
By Product
1. Introduction
  1. Product By Value
2. Neurosurgery Devices
  1. By Value
3. Neurostimulator
  1. By Value
4. Cerebrospinal Fluid (CSF) Management Devices
  1. By Value
5. Other
  1. By Value
By Service and Treatment
1. Introduction
  1. Service and Treatment By Value
2. Electroencephalogram
  1. By Value
3. Intrathecal Baclofen Therapy
  1. By Value
4. Neurological Evaluations
  1. By Value
5. Vagal Nerve Stimulation
  1. By Value
By Neurological Subspecialty
1. Introduction
  1. Neurological Subspecialty By Value
2. Neuro-Oncology
  1. By Value
3. Neuromuscular
  1. By Value
4. Neonatal Neurology
  1. By Value
5. Neuro-Immunology
  1. By Value
6. Stroke
  1. By Value
By Age Group
1. Introduction
  1. Age Group By Value
2. Neonates
  1. By Value
3. Infants
  1. By Value
4. Children
  1. By Value
5. Adolescents
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospital
  1. By Value
3. Healthcare Center
  1. By Value
4. Specialty Clinics
  1. By Value
5. Neurological Research Centres
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Brain Tumour
  1. By Value
3. Epilepsy
  1. By Value
4. Autism Spectrum Disorder
  1. By Value
5. Parkinson’s Disease
  1. By Value
6. Others
  1. By Value

North America Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Neurosurgery Devices
  1. By Value
3. Neurostimulator
  1. By Value
4. Cerebrospinal Fluid (CSF) Management Devices
  1. By Value
5. Other
  1. By Value
By Service and Treatment
1. Introduction
  1. Service and Treatment By Value
2. Electroencephalogram
  1. By Value
3. Intrathecal Baclofen Therapy
  1. By Value
4. Neurological Evaluations
  1. By Value
5. Vagal Nerve Stimulation
  1. By Value
By Neurological Subspecialty
1. Introduction
  1. Neurological Subspecialty By Value
2. Neuro-Oncology
  1. By Value
3. Neuromuscular
  1. By Value
4. Neonatal Neurology
  1. By Value
5. Neuro-Immunology
  1. By Value
6. Stroke
  1. By Value
By Age Group
1. Introduction
  1. Age Group By Value
2. Neonates
  1. By Value
3. Infants
  1. By Value
4. Children
  1. By Value
5. Adolescents
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospital
  1. By Value
3. Healthcare Center
  1. By Value
4. Specialty Clinics
  1. By Value
5. Neurological Research Centres
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Brain Tumour
  1. By Value
3. Epilepsy
  1. By Value
4. Autism Spectrum Disorder
  1. By Value
5. Parkinson’s Disease
  1. By Value
6. Others
  1. By Value
U.S.
1. By Product
  1. Introduction
    1. Product By Value
  2. Neurosurgery Devices
    1. By Value
  3. Neurostimulator
    1. By Value
  4. Cerebrospinal Fluid (CSF) Management Devices
    1. By Value
  5. Other
    1. By Value
2. By Service and Treatment
  1. Introduction
    1. Service and Treatment By Value
  2. Electroencephalogram
    1. By Value
  3. Intrathecal Baclofen Therapy
    1. By Value
  4. Neurological Evaluations
    1. By Value
  5. Vagal Nerve Stimulation
    1. By Value
3. By Neurological Subspecialty
  1. Introduction
    1. Neurological Subspecialty By Value
  2. Neuro-Oncology
    1. By Value
  3. Neuromuscular
    1. By Value
  4. Neonatal Neurology
    1. By Value
  5. Neuro-Immunology
    1. By Value
  6. Stroke
    1. By Value
4. By Age Group
  1. Introduction
    1. Age Group By Value
  2. Neonates
    1. By Value
  3. Infants
    1. By Value
  4. Children
    1. By Value
  5. Adolescents
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospital
    1. By Value
  3. Healthcare Center
    1. By Value
  4. Specialty Clinics
    1. By Value
  5. Neurological Research Centres
    1. By Value
6. By Application
  1. Introduction
    1. Application By Value
  2. Brain Tumour
    1. By Value
  3. Epilepsy
    1. By Value
  4. Autism Spectrum Disorder
    1. By Value
  5. Parkinson’s Disease
    1. By Value
  6. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Neurosurgery Devices
  1. By Value
3. Neurostimulator
  1. By Value
4. Cerebrospinal Fluid (CSF) Management Devices
  1. By Value
5. Other
  1. By Value
By Service and Treatment
1. Introduction
  1. Service and Treatment By Value
2. Electroencephalogram
  1. By Value
3. Intrathecal Baclofen Therapy
  1. By Value
4. Neurological Evaluations
  1. By Value
5. Vagal Nerve Stimulation
  1. By Value
By Neurological Subspecialty
1. Introduction
  1. Neurological Subspecialty By Value
2. Neuro-Oncology
  1. By Value
3. Neuromuscular
  1. By Value
4. Neonatal Neurology
  1. By Value
5. Neuro-Immunology
  1. By Value
6. Stroke
  1. By Value
By Age Group
1. Introduction
  1. Age Group By Value
2. Neonates
  1. By Value
3. Infants
  1. By Value
4. Children
  1. By Value
5. Adolescents
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospital
  1. By Value
3. Healthcare Center
  1. By Value
4. Specialty Clinics
  1. By Value
5. Neurological Research Centres
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Brain Tumour
  1. By Value
3. Epilepsy
  1. By Value
4. Autism Spectrum Disorder
  1. By Value
5. Parkinson’s Disease
  1. By Value
6. Others
  1. By Value
U.K.
1. By Product
  1. Introduction
    1. Product By Value
  2. Neurosurgery Devices
    1. By Value
  3. Neurostimulator
    1. By Value
  4. Cerebrospinal Fluid (CSF) Management Devices
    1. By Value
  5. Other
    1. By Value
2. By Service and Treatment
  1. Introduction
    1. Service and Treatment By Value
  2. Electroencephalogram
    1. By Value
  3. Intrathecal Baclofen Therapy
    1. By Value
  4. Neurological Evaluations
    1. By Value
  5. Vagal Nerve Stimulation
    1. By Value
3. By Neurological Subspecialty
  1. Introduction
    1. Neurological Subspecialty By Value
  2. Neuro-Oncology
    1. By Value
  3. Neuromuscular
    1. By Value
  4. Neonatal Neurology
    1. By Value
  5. Neuro-Immunology
    1. By Value
  6. Stroke
    1. By Value
4. By Age Group
  1. Introduction
    1. Age Group By Value
  2. Neonates
    1. By Value
  3. Infants
    1. By Value
  4. Children
    1. By Value
  5. Adolescents
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospital
    1. By Value
  3. Healthcare Center
    1. By Value
  4. Specialty Clinics
    1. By Value
  5. Neurological Research Centres
    1. By Value
6. By Application
  1. Introduction
    1. Application By Value
  2. Brain Tumour
    1. By Value
  3. Epilepsy
    1. By Value
  4. Autism Spectrum Disorder
    1. By Value
  5. Parkinson’s Disease
    1. By Value
  6. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Neurosurgery Devices
  1. By Value
3. Neurostimulator
  1. By Value
4. Cerebrospinal Fluid (CSF) Management Devices
  1. By Value
5. Other
  1. By Value
By Service and Treatment
1. Introduction
  1. Service and Treatment By Value
2. Electroencephalogram
  1. By Value
3. Intrathecal Baclofen Therapy
  1. By Value
4. Neurological Evaluations
  1. By Value
5. Vagal Nerve Stimulation
  1. By Value
By Neurological Subspecialty
1. Introduction
  1. Neurological Subspecialty By Value
2. Neuro-Oncology
  1. By Value
3. Neuromuscular
  1. By Value
4. Neonatal Neurology
  1. By Value
5. Neuro-Immunology
  1. By Value
6. Stroke
  1. By Value
By Age Group
1. Introduction
  1. Age Group By Value
2. Neonates
  1. By Value
3. Infants
  1. By Value
4. Children
  1. By Value
5. Adolescents
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospital
  1. By Value
3. Healthcare Center
  1. By Value
4. Specialty Clinics
  1. By Value
5. Neurological Research Centres
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Brain Tumour
  1. By Value
3. Epilepsy
  1. By Value
4. Autism Spectrum Disorder
  1. By Value
5. Parkinson’s Disease
  1. By Value
6. Others
  1. By Value
China
1. By Product
  1. Introduction
    1. Product By Value
  2. Neurosurgery Devices
    1. By Value
  3. Neurostimulator
    1. By Value
  4. Cerebrospinal Fluid (CSF) Management Devices
    1. By Value
  5. Other
    1. By Value
2. By Service and Treatment
  1. Introduction
    1. Service and Treatment By Value
  2. Electroencephalogram
    1. By Value
  3. Intrathecal Baclofen Therapy
    1. By Value
  4. Neurological Evaluations
    1. By Value
  5. Vagal Nerve Stimulation
    1. By Value
3. By Neurological Subspecialty
  1. Introduction
    1. Neurological Subspecialty By Value
  2. Neuro-Oncology
    1. By Value
  3. Neuromuscular
    1. By Value
  4. Neonatal Neurology
    1. By Value
  5. Neuro-Immunology
    1. By Value
  6. Stroke
    1. By Value
4. By Age Group
  1. Introduction
    1. Age Group By Value
  2. Neonates
    1. By Value
  3. Infants
    1. By Value
  4. Children
    1. By Value
  5. Adolescents
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospital
    1. By Value
  3. Healthcare Center
    1. By Value
  4. Specialty Clinics
    1. By Value
  5. Neurological Research Centres
    1. By Value
6. By Application
  1. Introduction
    1. Application By Value
  2. Brain Tumour
    1. By Value
  3. Epilepsy
    1. By Value
  4. Autism Spectrum Disorder
    1. By Value
  5. Parkinson’s Disease
    1. By Value
  6. Others
    1. By Value
Korea
Japan
India
Australia
Singapore
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Neurosurgery Devices
  1. By Value
3. Neurostimulator
  1. By Value
4. Cerebrospinal Fluid (CSF) Management Devices
  1. By Value
5. Other
  1. By Value
By Service and Treatment
1. Introduction
  1. Service and Treatment By Value
2. Electroencephalogram
  1. By Value
3. Intrathecal Baclofen Therapy
  1. By Value
4. Neurological Evaluations
  1. By Value
5. Vagal Nerve Stimulation
  1. By Value
By Neurological Subspecialty
1. Introduction
  1. Neurological Subspecialty By Value
2. Neuro-Oncology
  1. By Value
3. Neuromuscular
  1. By Value
4. Neonatal Neurology
  1. By Value
5. Neuro-Immunology
  1. By Value
6. Stroke
  1. By Value
By Age Group
1. Introduction
  1. Age Group By Value
2. Neonates
  1. By Value
3. Infants
  1. By Value
4. Children
  1. By Value
5. Adolescents
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospital
  1. By Value
3. Healthcare Center
  1. By Value
4. Specialty Clinics
  1. By Value
5. Neurological Research Centres
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Brain Tumour
  1. By Value
3. Epilepsy
  1. By Value
4. Autism Spectrum Disorder
  1. By Value
5. Parkinson’s Disease
  1. By Value
6. Others
  1. By Value
UAE
1. By Product
  1. Introduction
    1. Product By Value
  2. Neurosurgery Devices
    1. By Value
  3. Neurostimulator
    1. By Value
  4. Cerebrospinal Fluid (CSF) Management Devices
    1. By Value
  5. Other
    1. By Value
2. By Service and Treatment
  1. Introduction
    1. Service and Treatment By Value
  2. Electroencephalogram
    1. By Value
  3. Intrathecal Baclofen Therapy
    1. By Value
  4. Neurological Evaluations
    1. By Value
  5. Vagal Nerve Stimulation
    1. By Value
3. By Neurological Subspecialty
  1. Introduction
    1. Neurological Subspecialty By Value
  2. Neuro-Oncology
    1. By Value
  3. Neuromuscular
    1. By Value
  4. Neonatal Neurology
    1. By Value
  5. Neuro-Immunology
    1. By Value
  6. Stroke
    1. By Value
4. By Age Group
  1. Introduction
    1. Age Group By Value
  2. Neonates
    1. By Value
  3. Infants
    1. By Value
  4. Children
    1. By Value
  5. Adolescents
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospital
    1. By Value
  3. Healthcare Center
    1. By Value
  4. Specialty Clinics
    1. By Value
  5. Neurological Research Centres
    1. By Value
6. By Application
  1. Introduction
    1. Application By Value
  2. Brain Tumour
    1. By Value
  3. Epilepsy
    1. By Value
  4. Autism Spectrum Disorder
    1. By Value
  5. Parkinson’s Disease
    1. By Value
  6. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Neurosurgery Devices
  1. By Value
3. Neurostimulator
  1. By Value
4. Cerebrospinal Fluid (CSF) Management Devices
  1. By Value
5. Other
  1. By Value
By Service and Treatment
1. Introduction
  1. Service and Treatment By Value
2. Electroencephalogram
  1. By Value
3. Intrathecal Baclofen Therapy
  1. By Value
4. Neurological Evaluations
  1. By Value
5. Vagal Nerve Stimulation
  1. By Value
By Neurological Subspecialty
1. Introduction
  1. Neurological Subspecialty By Value
2. Neuro-Oncology
  1. By Value
3. Neuromuscular
  1. By Value
4. Neonatal Neurology
  1. By Value
5. Neuro-Immunology
  1. By Value
6. Stroke
  1. By Value
By Age Group
1. Introduction
  1. Age Group By Value
2. Neonates
  1. By Value
3. Infants
  1. By Value
4. Children
  1. By Value
5. Adolescents
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospital
  1. By Value
3. Healthcare Center
  1. By Value
4. Specialty Clinics
  1. By Value
5. Neurological Research Centres
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Brain Tumour
  1. By Value
3. Epilepsy
  1. By Value
4. Autism Spectrum Disorder
  1. By Value
5. Parkinson’s Disease
  1. By Value
6. Others
  1. By Value
Brazil
1. By Product
  1. Introduction
    1. Product By Value
  2. Neurosurgery Devices
    1. By Value
  3. Neurostimulator
    1. By Value
  4. Cerebrospinal Fluid (CSF) Management Devices
    1. By Value
  5. Other
    1. By Value
2. By Service and Treatment
  1. Introduction
    1. Service and Treatment By Value
  2. Electroencephalogram
    1. By Value
  3. Intrathecal Baclofen Therapy
    1. By Value
  4. Neurological Evaluations
    1. By Value
  5. Vagal Nerve Stimulation
    1. By Value
3. By Neurological Subspecialty
  1. Introduction
    1. Neurological Subspecialty By Value
  2. Neuro-Oncology
    1. By Value
  3. Neuromuscular
    1. By Value
  4. Neonatal Neurology
    1. By Value
  5. Neuro-Immunology
    1. By Value
  6. Stroke
    1. By Value
4. By Age Group
  1. Introduction
    1. Age Group By Value
  2. Neonates
    1. By Value
  3. Infants
    1. By Value
  4. Children
    1. By Value
  5. Adolescents
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospital
    1. By Value
  3. Healthcare Center
    1. By Value
  4. Specialty Clinics
    1. By Value
  5. Neurological Research Centres
    1. By Value
6. By Application
  1. Introduction
    1. Application By Value
  2. Brain Tumour
    1. By Value
  3. Epilepsy
    1. By Value
  4. Autism Spectrum Disorder
    1. By Value
  5. Parkinson’s Disease
    1. By Value
  6. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Pediatric Neurology Device Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Abbott
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Medtronic
Stryker Corporation
Boston Scientific
Braun
Integra LifeSciences
Nihon Kohden
Natus Medical
Cadwell Industries
neurocare group AG
Anuncia Medical Inc.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment

Appendix

Discussion Guide
Customization Options
Related Reports

Disclaimer

Get This Report

Our Clients:

Hindustan National Glass & Industries Limited

Table Of Content

Download Free Sample

Jay Mehta

Research Analyst